TY - JOUR
T1 - Native aortic valve derived extracellular matrix hydrogel for three dimensional culture analyses with improved biomimetic properties
AU - Nehrenheim, Laura
AU - Raschke, Silja
AU - Stefanski, Anja
AU - Barth, Mareike
AU - Selig, Jessica Isabel
AU - Barbian, Andreas
AU - Fernández-Colino, Alicia
AU - Stühler, Kai
AU - Mela, Petra
AU - Albert, Alexander
AU - Lichtenberg, Artur
AU - Akhyari, Payam
N1 - Publisher Copyright:
© 2019 IOP Publishing Ltd.
PY - 2019/4/5
Y1 - 2019/4/5
N2 - Introduction: Calcific aortic valve disease (CAVD) is the most common acquired heart valve disease with complex underlying pathomechanisms that are yet not fully understood. Three-dimensional (3D) cell culture models as opposed to conventional two-dimensional (2D) techniques may reveal new aspects of CAVD and serve as a transitional platform between conventional 2D cell culture and in vivo experiments. Methods: Here we report on fabrication and characterization of a novel 3D hydrogel derived from cell-free native aortic valves. A detailed analysis containing protein composition, rheological behavior, cytotoxic and proliferative effects as well as results of 3D cell culture experiments are presented. Moreover, this aortic valve derived hydrogel (AVdH) is compared to commercially available biological extracellular matrix (ECM) components to evaluate and classify AVdH with respect to other currently used ECM solutions, i.e. Collagen type I and Matrigel®. Results: On the biochemical level, a complex composition of native proteins was detected. Using different techniques, including mass spectrometry with Gene Ontology network and enrichment analysis, different fundamental biological functions of AVdH were identified, including peptidase-, peptidase inhibitor-, growth- and binding activity. No cytotoxic effects were detected and AVdH showed positive effects on cell growth and proliferation in vitro when compared to Collagen type I and Matrigel®. Conclusion: These results suggest AVdH as an organotypic ECM supporting sophisticated 3D cell culture model studies, while mimicking the native environment of the aortic valve to a greater level for enhanced in vitro analyses.
AB - Introduction: Calcific aortic valve disease (CAVD) is the most common acquired heart valve disease with complex underlying pathomechanisms that are yet not fully understood. Three-dimensional (3D) cell culture models as opposed to conventional two-dimensional (2D) techniques may reveal new aspects of CAVD and serve as a transitional platform between conventional 2D cell culture and in vivo experiments. Methods: Here we report on fabrication and characterization of a novel 3D hydrogel derived from cell-free native aortic valves. A detailed analysis containing protein composition, rheological behavior, cytotoxic and proliferative effects as well as results of 3D cell culture experiments are presented. Moreover, this aortic valve derived hydrogel (AVdH) is compared to commercially available biological extracellular matrix (ECM) components to evaluate and classify AVdH with respect to other currently used ECM solutions, i.e. Collagen type I and Matrigel®. Results: On the biochemical level, a complex composition of native proteins was detected. Using different techniques, including mass spectrometry with Gene Ontology network and enrichment analysis, different fundamental biological functions of AVdH were identified, including peptidase-, peptidase inhibitor-, growth- and binding activity. No cytotoxic effects were detected and AVdH showed positive effects on cell growth and proliferation in vitro when compared to Collagen type I and Matrigel®. Conclusion: These results suggest AVdH as an organotypic ECM supporting sophisticated 3D cell culture model studies, while mimicking the native environment of the aortic valve to a greater level for enhanced in vitro analyses.
KW - CAVD
KW - aortic valve
KW - biommetic material
KW - cardiac tissue engineering
KW - hydrogel model
UR - http://www.scopus.com/inward/record.url?scp=85064317142&partnerID=8YFLogxK
U2 - 10.1088/1748-605X/ab0791
DO - 10.1088/1748-605X/ab0791
M3 - Article
C2 - 30769335
AN - SCOPUS:85064317142
SN - 1748-6041
VL - 14
JO - Biomedical Materials
JF - Biomedical Materials
IS - 3
M1 - 035014
ER -